In today’s conversation we are going to learn about bioinformatics - an evolving biotech discipline that uses software to help us better understand biological data. Bionformatics is key to innovation in the current drug discovery process and disease prevention. To that end we are joined by a PhD in Genome Science, based in Tokyo - Eli Lyons, CEO of Tupac Bio.
Although Biotech is a highly skilled and technologically driven industry, it can often be slowed by traditional or internally focused worldviews. Eli applies his training as an engineer to a fundamentally biological problem to drive innovation. In this interview, Eli shares his own views on how being an outsider within any industry can yield new ways of thinking.
3 Startup Entrepreneurs Pioneering Asia’s $100 Billion Health Tech Industry
Asia’s health tech industry is worth over $100 billion. With a combination of aging populations, an emerging wealthy middle class and populations of billions, Asia is a land of opportunity. In this feature, we highlight 3 startup entrepreneurs pioneering the Asian health tech industry - from redefining pharmaceutical field sales to patient-doctor interaction to genome science. Featuring: .>> Go to the full episode page